KARYOPHARM THERAPEUTICS H-1B Visa Sponsorship & Salary Data
KARYOPHARM THERAPEUTICS has filed 44 H-1B labor condition applications from FY 2020 to FY 2026, with 41 certified. The median H-1B salary at KARYOPHARM THERAPEUTICS is $130,000, which is 8% higher than the national H-1B median of $120,000.
Salary Analysis
Salary Range
- 10th percentile: $100,000
- 25th percentile: $110,000
- Median: $130,000
- 75th percentile: $153,480
- 90th percentile: $170,000
Wage Level Distribution
- Level I (Entry): 1 (2%)
- Level II (Qualified): 12 (29%)
- Level III (Experienced): 10 (24%)
- Level IV (Expert): 18 (44%)
Trend (2020-2026)
- Starting median: $120,000
- Current median: $153,480
- Growth: +28%
Salary & Hiring Visualizations
Salary Distribution
Distribution of H-1B salaries at KARYOPHARM THERAPEUTICS
KARYOPHARM THERAPEUTICS's H-1B salaries range from $100,000 to $170,000 (10th-90th percentile), with a median of $130,000. This is 8% above the national H-1B median.
Wage Level Distribution
DOL wage levels affect H-1B lottery priority
KARYOPHARM THERAPEUTICS files 98% of H-1B positions at Level II or higher. Higher wage levels receive priority in the H-1B lottery, giving KARYOPHARM THERAPEUTICS candidates a competitive advantage.
Median Salary Trend
Year-over-year salary changes
KARYOPHARM THERAPEUTICS's median H-1B salary increased by +28% from FY 2020 ($120,000) to FY 2026 ($153,480). This strong growth reflects competitive compensation adjustments.
H-1B Filings by Year
Annual hiring activity through H-1B program
KARYOPHARM THERAPEUTICS's H-1B filings changed by -91% from FY 2020 to FY 2026. This may reflect changes in hiring strategy or workforce composition.
Salary by Job Title
Top H-1B job titles at this employer
The highest-volume H-1B role at KARYOPHARM THERAPEUTICS is Clinical Data Manager with 4 filings at $100,942 median salary.
Salary by Location
Salary distribution across office locations (sorted by median)
KARYOPHARM THERAPEUTICS's largest H-1B hub is Newton, MA with 30 filings. The highest-paying location is Merced, CA at $170,475 median.
Highest Paying H-1B Roles at KARYOPHARM THERAPEUTICS
Ranked by median salary — Unlike "Salary by Job Title" above which shows the most common roles by filing volume, this section ranks all H-1B positions by their median compensation to highlight the best-paying opportunities.
These are the top 10 highest-paying H-1B job titles at KARYOPHARM THERAPEUTICS, ranked by median salary. The highest-paying role is Associate Director, Xpovio U.S. Multiple Myeloma Marketing at $169,000 median, which is 30% above the company's overall H-1B median of $130,000.
High-paying H-1B roles typically require advanced technical expertise, specialized domain knowledge, or significant leadership responsibility. Factors influencing top-tier compensation include years of experience, educational credentials (PhD, Master's degrees), rare skill combinations, and market demand for specific technologies. The salary distribution chart below each role shows how compensation varies—wider distributions indicate more salary negotiation flexibility, while narrow peaks suggest standardized pay bands. Senior and principal-level positions consistently command premium salaries due to their strategic impact and scarcity of qualified candidates.
Associate Director, Xpovio U.S. Multiple Myeloma Marketing
2 H-1B filings at KARYOPHARM THERAPEUTICS
Senior Research Scientist
3 H-1B filings at KARYOPHARM THERAPEUTICS
Research Scientist
3 H-1B filings at KARYOPHARM THERAPEUTICS
Senior Associate, Regulatory Operations
2 H-1B filings at KARYOPHARM THERAPEUTICS
Senior Clinical Data Manager
3 H-1B filings at KARYOPHARM THERAPEUTICS
Clinical Data Manager
4 H-1B filings at KARYOPHARM THERAPEUTICS
Salary data based on 41 certified H-1B labor condition applications at KARYOPHARM THERAPEUTICS. Actual compensation may vary based on experience, specific role requirements, and location within the company.
Highest Individual H-1B Salaries at KARYOPHARM THERAPEUTICS
Actual filed salaries — These are the 10 highest individual H-1B salary filings at KARYOPHARM THERAPEUTICS, representing specific positions (not aggregated medians). These may include executive, highly specialized, or senior leadership roles.
The highest H-1B salary filed at KARYOPHARM THERAPEUTICS was $265,000 for a Senior Medical Director, Pharmacovigilance position in Newton, MA (FY2021). This is 104% higher than the company's median H-1B salary.
Top H-1B salaries often cluster in high cost-of-living metros like San Francisco, New York, and Seattle where prevailing wages are higher. However, executive and specialized roles can command premium compensation regardless of location. These filings represent the upper bound of H-1B compensation at KARYOPHARM THERAPEUTICS—actual total compensation may be significantly higher when including stock grants, bonuses, and benefits. Geographic patterns in top salaries often reflect where companies locate their most senior technical talent and leadership positions.
| Rank | Job Title | Location | Salary | Level | Year |
|---|---|---|---|---|---|
| 1 | Senior Medical Director, Pharmacovigilance | Newton, MA | $265,000 | IV | FY 2021 |
| 2 | Senior Medical Director, Pharmacovigilance | Newton, MA | $265,000 | IV | FY 2022 |
| 3 | Senior Biostatistician | Newton, MA | $187,044 | IV | FY 2025 |
| 4 | Associate Director/Director, Clinical Pharmacology And Dmpk | Merced, CA | $170,475 | IV | FY 2022 |
| 5 | Associate Director/Director, Clinical Pharmacology And Dmpk | Exton, PA | $170,000 | IV | FY 2021 |
| 6 | Senior Manager, Regulatory Operations | Newton, MA | $170,000 | III | FY 2023 |
| 7 | Associate Director, Xpovio U.S. Multiple Myeloma Marketing | Newton, MA | $169,000 | III | FY 2022 |
| 8 | Associate Director, Xpovio U.S. Multiple Myeloma Marketing | Newton, MA | $165,000 | III | FY 2020 |
| 9 | Senior Manager, Regulatory Operations | Newton, MA | $160,685 | III | FY 2023 |
| 10 | Sr. Clinical Trial Manager | Newton, MA | $160,000 | IV | FY 2023 |
These represent the highest individual salary amounts filed in H-1B labor condition applications. Note: H-1B salary data reflects base compensation only and does not include stock options, RSUs, bonuses, or other benefits which can significantly increase total compensation at tech companies.
Detailed Breakdown
H-1B Job Titles at KARYOPHARM THERAPEUTICS
| Job Title | Filings | Median Salary |
|---|---|---|
| Clinical Data Manager | 4 | $100,942 |
| Research Scientist | 3 | $135,000 |
| Senior Research Scientist | 3 | $145,000 |
| Senior Clinical Data Manager | 3 | $124,500 |
| Senior Associate, Regulatory Operations | 2 | $133,900 |
| Associate Director, Xpovio U.S. Multiple Myeloma Marketing | 2 | $169,000 |
H-1B Locations for KARYOPHARM THERAPEUTICS
| Location | Filings | Median Salary |
|---|---|---|
| Newton, MA | 30 | $133,900 |
| Farmington, AR | 2 | $132,657 |
| Exton, PA | 1 | $170,000 |
| Albuquerque, NM | 1 | $100,942 |
| Merced, CA | 1 | $170,475 |
| Centerville, VA | 1 | $120,000 |
| Apex, NC | 1 | $120,000 |
| Des Plaines, IL | 1 | $130,000 |
| Edgewater, NJ | 1 | $124,747 |
| Haymarket, VA | 1 | $132,717 |
Recent H-1B Filings at KARYOPHARM THERAPEUTICS
Sample of 20 recent certified H-1B labor condition applications. This represents a small fraction of KARYOPHARM THERAPEUTICS's 41 total certified filings.
| Job Title | Location | Salary | Level | Year |
|---|---|---|---|---|
| Senior Research Scientist | Newton, MA | $153,480 | IV | FY 2026 |
| Senior Biostatistician | Newton, MA | $187,044 | IV | FY 2025 |
| Senior Statistical Programmer 1 | Newton, MA | $123,966 | III | FY 2025 |
| Sr Clinical Data Manager | Haymarket, VA | $132,717 | II | FY 2025 |
| Gcp Documentation Specialist | Newton, MA | $96,616 | II | FY 2025 |
| Senior Clinical Data Manager | Farmington, AR | $132,657 | IV | FY 2025 |
| Manager, Regulatory Operations | Morrisville, NC | $139,932 | IV | FY 2025 |
| Senior Clinical Data Manager | Farmington, AR | $124,500 | III | FY 2024 |
| Sr Clinical Data Manager | Centerville, VA | $120,000 | II | FY 2023 |
| Senior Clinical Data Manager | Apex, NC | $120,000 | III | FY 2023 |
| Manager, Regulatory Operations | Des Plaines, IL | $130,000 | IV | FY 2023 |
| Associate Director, Ist Operations | Edgewater, NJ | $124,747 | IV | FY 2023 |
| Manager Regulatory Operations | Newton, MA | $109,745 | IV | FY 2023 |
| Senior Manager, Regulatory Operations | Newton, MA | $160,685 | III | FY 2023 |
| Senior Manager, Regulatory Operations | Newton, MA | $170,000 | III | FY 2023 |
| Senior Research Scientist | Newton, MA | $143,763 | IV | FY 2023 |
| Sr. Clinical Trial Manager | Newton, MA | $160,000 | IV | FY 2023 |
| Clinical Data Manager | Albuquerque, NM | $100,942 | IV | FY 2022 |
| Senior Biostatistician | Newton, MA | $149,968 | IV | FY 2022 |
| Associate Director, Xpovio U.S. Multiple Myeloma Marketing | Newton, MA | $169,000 | III | FY 2022 |
Data source: U.S. Department of Labor LCA Disclosure Files. Showing most recent certified filings.
Frequently Asked Questions about KARYOPHARM THERAPEUTICS H-1B Visas
What is the average H-1B salary at KARYOPHARM THERAPEUTICS?
The median H-1B salary at KARYOPHARM THERAPEUTICS is $130,000, based on 41 certified filings from FY 2020 to FY 2026. This is 8% higher than the national H-1B median salary of $120,000. Compensation at KARYOPHARM THERAPEUTICS reflects their market positioning, with entry-level roles starting around $110,000 and senior positions reaching $170,000 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.
Salaries at KARYOPHARM THERAPEUTICS range from $100,000 at the 10th percentile to $170,000 at the 90th percentile, showing a $70,000 spread across experience levels and roles. The 25th percentile is $110,000 and the 75th percentile is $153,480.
Does KARYOPHARM THERAPEUTICS sponsor H-1B visas?
Yes, KARYOPHARM THERAPEUTICS actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 44 H-1B labor condition applications from FY 2020 to FY 2026, demonstrating ongoing commitment to hiring international talent. With 41 certified applications and a 0% denial rate, KARYOPHARM THERAPEUTICS maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.
In the most recent fiscal year (FY 2026), KARYOPHARM THERAPEUTICS filed 1 H-1B applications, with 1 certified and 0 denied. Over 7 years of data, KARYOPHARM THERAPEUTICS has consistently demonstrated commitment to H-1B sponsorship.
Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.
What is KARYOPHARM THERAPEUTICS's H-1B approval rate?
KARYOPHARM THERAPEUTICS's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 44 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating KARYOPHARM THERAPEUTICS as a potential H-1B sponsor.
This is an excellent approval rate, indicating KARYOPHARM THERAPEUTICS has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.
What jobs does KARYOPHARM THERAPEUTICS sponsor for H-1B?
KARYOPHARM THERAPEUTICS sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 41 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles KARYOPHARM THERAPEUTICS most frequently sponsors can help job seekers target their applications effectively.
Most common H-1B job titles at KARYOPHARM THERAPEUTICS:
The most frequently sponsored role is Clinical Data Manager with 4 filings at a median salary of $100,942. This is followed by Research Scientist (3 filings) and Senior Research Scientist.
Where are KARYOPHARM THERAPEUTICS's H-1B jobs located?
KARYOPHARM THERAPEUTICS's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where KARYOPHARM THERAPEUTICS sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.
Top KARYOPHARM THERAPEUTICS H-1B locations:
The largest H-1B hub for KARYOPHARM THERAPEUTICS is Newton, MA with 30 filings at a median salary of $133,900. The highest-paying location is Merced, CA at $170,475 median. Salaries range from $100,942 to $170,475 across office locations.
How have KARYOPHARM THERAPEUTICS's H-1B salaries changed over time?
KARYOPHARM THERAPEUTICS's median H-1B salary has increased by +28% from FY 2020 ($120,000) to FY 2026 ($153,480). Tracking salary trends over time reveals how KARYOPHARM THERAPEUTICS adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at KARYOPHARM THERAPEUTICS.
Year-by-year breakdown:
- FY 2022: $149,968 (8 certified)
- FY 2023: $130,000 (9 certified)
- FY 2024: $124,500 (1 certified)
- FY 2025: $132,717 (6 certified)
- FY 2026: $153,480 (1 certified)
This 28% growth reflects strong compensation adjustments at KARYOPHARM THERAPEUTICS, keeping pace with market demands for H-1B talent.
What wage level does KARYOPHARM THERAPEUTICS use for H-1B?
KARYOPHARM THERAPEUTICS primarily files H-1B applications at Wage Level IV, accounting for 44% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making KARYOPHARM THERAPEUTICS's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.
With 98% of positions at Level II or higher, KARYOPHARM THERAPEUTICS typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.
How does KARYOPHARM THERAPEUTICS's H-1B salary compare to other employers?
KARYOPHARM THERAPEUTICS's median H-1B salary of $130,000 is 8% higher than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating KARYOPHARM THERAPEUTICS's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare KARYOPHARM THERAPEUTICS's offerings with similar companies in your field for a more accurate assessment.
KARYOPHARM THERAPEUTICS offers above-average H-1B compensation. Combined with their 41 certified filings and 0% denial rate, they demonstrate solid H-1B sponsorship practices.
How do new H-1B fees and rules affect KARYOPHARM THERAPEUTICS's sponsorship?
Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. KARYOPHARM THERAPEUTICS's higher proportion of Level III-IV positions (68%) may benefit from wage-based lottery prioritization.
With 41 certified filings, KARYOPHARM THERAPEUTICS invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.
Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.
Companies Similar to KARYOPHARM THERAPEUTICS
Employers with similar H-1B salary ranges and filing volumes.
Explore Major H-1B Employers
These top H-1B sponsors have comprehensive salary data and filing history:
View all employers →